Assessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch

Simply Wall St.01-17

Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2604450789?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","is_english":true,"pubTime":"2026-01-17 12:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604450789","market":"nz","top_or_hot":-1,"title":"Assessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch","media":"Simply Wall St.","content":"<div>\n<p>Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Oddity Tech (ODD) Valuation After Analyst Praise And METHODIQ Skincare Launch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-17 12:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and","article_id":"2604450789","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nasdaq-odd/oddity-tech/news/assessing-oddity-tech-odd-valuation-after-analyst-praise-and","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604450789","pubTimestamp":1768624166,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has helped lift investor interest in the stock.\nSee our latest analysis for Oddity Tech.\nAt a share price of $35.34, Oddity Tech has seen a 4.56% 1 day share price return, but weaker 30 day and 90 day share price returns of 16.34% and 30.50%, with a 1 year total shareholder return of 19.39%. This...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4528":"SaaS概念","BK4601":"加密货币现货ETF","BK4543":"AI","ODD":"ODDITY Tech Ltd.","AI":"C3.ai, Inc.","BK4551":"寇图资本持仓","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4183":"个人用品","BK4587":"ChatGPT概念","ETH":"低成本以太坊ETF-Grayscale","NPL.SI":"新加坡阅肤有限公司","BK6100":"保健护理服务","BK4023":"应用软件"},"translate_title":"在分析师赞扬和METHODIQ护肤品推出后评估Oddity Tech(ODD)估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ODD":1.5,"ETH":1.5,"AI":0.62,"NPL.SI":1.5},"content_text":"Oddity Tech (NasdaqGM:ODD) is back in focus after an influential analyst highlighted its recent skincare launch, METHODIQ, along with consistent revenue growth and EBITDA margins near 20%, which has helped lift investor interest in the stock. See our latest analysis for Oddity Tech. At a share price of $35.34, Oddity Tech has seen a 4.56% 1 day share price return, but weaker 30 day and 90 day share price returns of 16.34% and 30.50%, with a 1 year total shareholder return of 19.39%. This points to fading momentum despite recent product and financing headlines. If METHODIQ and Oddity Labs have caught your attention, this could be a good moment to widen your watchlist with high growth tech and AI stocks that blend beauty, data and AI driven models. With revenue growth of 15.88%, net income growth of 17.32% and the shares trading at a reported 50% discount to one intrinsic value estimate, the key question is whether Oddity Tech is underappreciated at this level or whether the market is already pricing in years of future growth. AdvertisementMost Popular Narrative: 46.8% Undervalued With Oddity Tech closing at US$35.34 against a narrative fair value estimate of about US$66.45, the valuation gap this narrative outlines is substantial and rests on a very specific growth and profitability path.  Oddity's ongoing international expansion, with significant strengthening in existing and prospective new markets (e.g., France, Italy, Spain), is at a very early stage relative to peers but already generating >40% Y/Y growth and providing a long runway for revenue growth as it closes the gap with competitors whose businesses are 70% international (vs. 15% for Oddity). This should materially increase total addressable market and revenue in future periods.  Read the complete narrative. Curious how this early stage international mix, new healthcare verticals and projected margins all combine into that higher value per share? The narrative lays out detailed growth, earnings and valuation assumptions that connect today’s price to that higher fair value target. Result: Fair Value of $66.45 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you still need to weigh the risk that rising digital marketing costs or slower international uptake could pressure margins and challenge those higher fair value assumptions. Find out about the key risks to this Oddity Tech narrative.  Build Your Own Oddity Tech Narrative If you are not fully on board with this view or prefer to test the numbers yourself, you can build your own Oddity Tech story in just a few minutes by starting with Do it your way. A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Oddity Tech. Looking for more investment ideas? If Oddity Tech has sharpened your thinking, do not stop here. The screener can help you compare opportunities and pressure test where you put your next dollar.  Target potential bargains by scanning these 863 undervalued stocks based on cash flows that may offer more appealing prices relative to their underlying cash flows. Ride powerful tech trends by checking out these 24 AI penny stocks that are leaning heavily into artificial intelligence and automation. Boost your income focus by reviewing these 12 dividend stocks with yields > 3% that offer yields above 3% for cash flow minded portfolios.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604450789","isCrawlerRequest":true}